Department: Board of Directors & Corporate Advisors

President and CEO, Morehouse School of Medicine As a physician, prominent infertility specialist, and researcher who has experience at the top levels of patient care as well as organizational management and public health policy, Valerie Montgomery Rice, MD, FACOG, brings an invaluable combination of skills and experience. As a transformational leader, she combines strategic thinking…

Mr. Spencer joined the Board of Directors in September 2006. Mr. Spencer is a registered Certified Public Accountant in four states, and he was a Partner at Ernst & Young LLP (“EY”) where he spent more than 38 years until he retired in 2000. While at EY, Mr. Spencer was the partner in charge of…

Dr. Jayne Morgan is an accomplished Cardiologist and the Vice President of Medical Affairs for Hello Heart where she has a focus on Women’s Health and AI. With both an interest in menopause and women’s well being, Dr. Morgan was recently named by MidiHealth to the 45 over 45 list of top Women’s Health experts…

Dr McNally’s 40-year career spanned the medical biotech industry overseeing clinical research, quality and regulatory systems, and corporate management. As part of the management team, he brought CryoLife, Inc. from being one of the founders in 1984 to a listing on the NYSE in 1993. His numerous patents cover the preservation of human tissues for…

Nicole Lemerond is a public company board director and healthcare financial executive with over 25 years of experience in investment management, private equity, investment banking, mergers/acquisitions, and leveraged finance. She has significant experience executing complex transactions, managing diligence processes, raising capital and structuring balance sheets. Her breadth of industry expertise includes providers, payors, medical device…

Mr. Kollintzas joined the Board of Directors upon consummation of the merger with GeoVax, Inc. in September 2006. Since 2001 Mr. Kollintzas has been an intellectual property attorney specializing in biotechnology and pharmaceutical licensing, FDA regulation, and corporate/international transactions. Mr. Kollintzas received a microbiology degree from the University of Illinois and a J.D. from Franklin…

Dr. Chase is a highly experienced biotech executive who has held senior leadership positions for companies in Canada, the United States and the United Kingdom including publicly traded companies listed on the TSX, Amex , Nasdaq and FTSE. Dr. Chase joined the GeoVax Board in March 2015 where he serves on the Audit Committee, the…